Telomere Shortening Associated with Disease Evolution Patterns in Myelodysplastic Syndromes

Cancer Research

Volumn 54, Issue 13, 1994, Pages 3557-3560

  Ohyashiki, Junko H ^a   Ohyashiki, Kazuma ^a   Fujimura, Toshikatsu ^a   Kawakubo, Ken ^a   Shimamoto, Takashi ^a   Iwabuchi, Atsuhiro ^a   Toyama, Keisuke ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PALINDROMIC DNA;

ADULT; APLASTIC ANEMIA; ARTICLE; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SOUTHERN BLOTTING; TANDEM REPEAT; TELOMERE;

ACUTE DISEASE; ADULT; ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; ANEMIA, SIDEROBLASTIC; HUMAN; KARYOTYPING; LEUKEMIA, MYELOID; REPETITIVE SEQUENCES, NUCLEIC ACID; SUPPORT, NON-U.S. GOV'T; TELOMERE;

EID: 0028340950     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., and Sultan, C. Proposals for the classification of the myelodysplastic syndromes. Br. J. Haematol., 51: 189-199, 1982.
2. Mufti, G.J., and Galton, D.A. Myelodysplastic syndromes: natural history and features of prognostic importance. Gin. Haematol., 15: 953-971, 1986.
3. Foucar, K., Langdon, R.M., Armitage, J.O., Olson, D.B., and Carroll, T.J., Jr. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer (Phila.), 56: 553-561, 1985.
4. Tricot, G., Boogaerts, M.A., De Wolf-Peeters, C., Van den Berghe, H., and Verwilghen, R.L. The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations. Br. J. Haematol., 59: 659-670, 1985.
5. Third MIC Cooperative Study Group. Recommendations for a morphologic, immunologic and cytogenetic (MIC) working classification of the primary and therapyrelated myelodysplastic disorders. Cancer Genet. Cytogenet., 32: 1-10, 1988.
6. Billstrom, R., Thiede, T., Hansen, S., Heim, S., Kristoffersson, U., Mandahl, N., and Mittelman, F. Bone marrow karyotype and prognosis in primary myelodysplastic syndromes. Eur. J. Haematol., 41: 341-346, 1988.
7. Horiike, S., Taniwaki, M., Misawa, S., and Abe, T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer (Phila.), 62: 1129-1138, 1988.
8. Ohyashiki, K., Iwabuchi, A., Sasao, I., Ohyashiki, J.H., Ito, H., and Toyama, K. Clinical and cytogenetic significance of myelodysplastic syndromes with disease evolution. Cancer Genet. Cytogenet., 67: 71-78, 1993.
9. Blackburn, E.H. Structure and function of telomeres. Nature (Lond.), 350: 569-573, 1991.
10. Moyzis, R.K., Buckingham, J.M., Cram, L.S., Dani, M., Deaven, L.L., Jones, M.D., Meyne, J., Ratliff, R.L., and Wu, J.R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA, 85: 6622-6626, 1988.
11. de Lange, T., Shiue, L., Myers, R.M., Cox, D.R., Naylor, S.L., Killery, A.M., and Varmus, H.E. Structure and variability of human chromosome ends. Mol. Cell Biol., 10: 518-527, 1990.
12. Harley, C.B., Futcher, A.B., and Greider, C.W. Telomeres shorten during ageing of human fibroblasts. Nature (Lond.), 345: 458-460, 1990.
13. Hastie, N.D., Dempster, M., Dunlop, M.G., Thompson, A.M., Green, D.K., and Allshire, R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature (Lond.), 346: 866-868, 1990.
14. Allsopp, R.C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E.V., Futcher, A.B., Greider, C.W., and Harley, C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 10114-10118, 1992.
15. Counter, C.M., Avilion, A.A., LeFeuvre, C.E., Stewart, N.G., Greider, C.W., Harley, C.B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
16. Hiyama, E., Hiyama, K., Yokoyama, T., Ichikawa, T., and Matsuura, Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn. J. Cancer Res., 83: 159-164, 1992.
17. Yamada, O., Oshimi, K., and Mizoguchi, H. Telomere reduction in hematologic cells. Int. J. Hematol., 57: 181-186, 1993.
18. Adamson, D.J.A., King, D.J., and Haites, N.E. Significant telomere shortening in childhood leukemia. Cancer Genet. Cytogenet., 61: 204-206, 1992.
19. Mitelman, F. (ed.). Guidelines for Cancer Cytogenetics: Supplement to An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S. Karger AG, 1991.
20. Ohyashiki, J.H., Ohyashiki, K., Kawakubo, K., Tauchi, T., Nakazawa, S., Kimura, N., and Toyama, K. T-cell receptor β-chain gene rearrangement in acute myeloid leukemia always occurs at the allele that contains the undermethylated Jβ1 region. Cancer Res., 52: 6598-6602, 1992.
21. Ohyashiki, K., Ohyashiki, J.H., Fujimura, T., Kawakubo, K., Shimamoto, T., Saito, M., Nakazawa, S., and Toyama, K. Telomere shortening in leukemic cells is not related to their replicative capability. Cancer Genet. Cytogenet., in press, 1994.
22. Ohyashiki, K., Ohyashiki, J.H., Tauchi, T., Iwabuchi, H., Iwabuchi, A., and Toyama, K. ETS-1 gene in myelodysplastic syndrome with chromosome change at 11q23. Cancer Genet. Cytogenet., 45: 73-80, 1990.
23. Vogelstein, B., Fearon, E.R., Kern, S.E., Hamilton, S.R., Preisinger, A.C., Nakamura, Y., and White, R. Allotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
24. Sugimura, T. Multistep carcinogenesis: A 1992 perspective. Science (Washinton DC), 258: 603-607, 1992.
25. Ohyashiki, J.H., Ohyashiki, K., Kawakubo, K., Fujimura, T., Shimamoto, T., Nakazawa, S., Kimura, N., and Toyama, K. Comparison between immunogenotypic findings in de novo AML and AML post MDS. Leukemia (Baltimore), 7: 1747-1751, 1993.
26. Padua, R.A., Carter, G., and Hughes, D. RAS mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia (Baltimore), 2: 503-510, 1988.
27. Lyons, J., Janssen, J.W.G., Bartram, C.R., Layton, M., and Mufti, G.J. Mutations of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Blood, 71: 1707-1712, 1988.
28. Ridge, S.A., Worwood, M., Oscier, D., Jacobs, A., and Padua, R.A. FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc. Natl. Acad. Sci. USA, 87: 1377-1380, 1990.
29. Jonveaux, P., Fenaux, P., Quiquandon, I., Pignon, J.M., Loucheux-Lefebre, M.H., Goosens, M., Bauters, F., and Berger, R. Mutations of the p. 3 gene in myelodysplastic syndromes. Oncogene, 6: 2243-2247, 1991.
30. Ludwig, L., Schulz, A.S., Janssen, J.W.G., Grunewald, K., and Bartram, C.R. p. 3 mutations in myelodysplastic syndromes. Leukemia (Baltimore), 6: 1302-1304, 1992.
31. Tsushita, K., Hotta, T., Ichikawa, A., and Saito, H. Mutation of p. 3 gene does not play a critical role in myelodysplastic syndrome and its transformation to acute leukaemia. Br. J. Haematol., 82: 456-457, 1992.
32. Momand, J., Zambetti, G.P., Olson, D.C., George, D., and Levine, A.J. The MDM2 oncogene product forms a complex with the p. 3 protein and inhibits p. 3-mediated transactivation. Cell, 69: 1237-1245, 1992.
33. Preudhomme, C., Quesnel, B., Vachee, A., Lepelley, P., Collyn-D'Hooghe, M., Wattel, E., and Fenaux, P. Absence of amplification of MDM2 gene, a regulator of p. 3 function, in myelodysplastic syndromes. Leukemia (Baltimore), 7: 1291-1293, 1993.
34. Willman, C.L., Sever, C.E., Pallavicini, M.G., Harada, H., Tanaka, N., Slovak, M.L., Yamamoto, H., Harada, K., Meeker, T.C., List, A.F., and Taniguchi, T. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science (Washington DC), 259: 968-971, 1993.